Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$37,762,352
-$8,819,953 QoQ
Shares Held
1,568,204
-5.5% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#208
of 2,821 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $928,724,025 across 9 Drug Manufacturers - General names. PFE ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
257,172 | $308,459,837 | |
| 2 | JNJ |
Johnson & Johnson
|
753,095 | $191,263,537 | |
| 3 | ABBV |
AbbVie Inc.
|
548,411 | $138,002,144 | |
| 4 | MRK |
Merck & Co., Inc.
|
786,562 | $101,073,217 | |
| 5 | AMGN |
Amgen Inc
|
169,380 | $61,335,885 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
321,765 | $40,651,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
690,291 | $39,774,567 | |
| 8 | PFE |
Pfizer Inc
This page
|
1,568,204 | $37,762,352 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,762,352 | 1,568,204 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $46,582,305 | 1,658,914 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $33,615,000 | 1,350,000 | Shares | Sole | 2026-02-06 | |
| 2024-12-31 | $7,271,819 | 274,098 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,349,913 | 288,525 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $8,072,929 | 288,525 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,006,568 | 288,525 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $22,679,955 | 787,772 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $24,292,447 | 732,362 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $26,709,899 | 728,187 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $29,259,801 | 717,152 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $49,172,209 | 959,645 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $38,150,011 | 871,801 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $27,410,141 | 522,795 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $27,168,637 | 524,795 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $30,841,519 | 522,295 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $21,649,900 | 503,369 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $19,711,930 | 503,369 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $17,965,333 | 495,869 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $18,252,937 | 495,869 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $18,198,374 | 495,869 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $16,214,933 | 495,869 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $19,449,137 | 595,869 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||